Tongling Jieya Biologic Technology Co., Ltd. (SHE:301108)
China
· Delayed Price · Currency is CNY 27.06
+0.44 (1.65%)
At close: Apr 29, 2026
SHE:301108 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2018 |
| Market Capitalization | 3,046 | 3,744 | 2,070 | 2,805 | 2,742 | 4,886 | Upgrade
|
| Market Cap Growth | 47.70% | 80.83% | -26.20% | 2.31% | -43.89% | - | Upgrade
|
| Enterprise Value | 2,176 | 2,675 | 782 | 2,061 | 1,220 | 4,583 | Upgrade
|
| Last Close Price | 27.06 | 33.26 | 18.28 | 24.19 | 23.31 | 40.75 | Upgrade
|
| PE Ratio | 42.89 | 48.45 | 106.36 | 24.35 | 19.45 | 22.21 | Upgrade
|
| Forward PE | 12.59 | 16.26 | 14.31 | 19.19 | - | - | Upgrade
|
| PS Ratio | 3.62 | 4.85 | 3.78 | 4.51 | 4.11 | 4.96 | Upgrade
|
| PB Ratio | 1.61 | 1.99 | 1.13 | 1.51 | 1.54 | 2.89 | Upgrade
|
| P/TBV Ratio | 1.67 | 2.06 | 1.16 | 1.54 | 1.57 | 2.94 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 10.19 | 38.30 | Upgrade
|
| P/OCF Ratio | 24.51 | 37.75 | 27.56 | 33.59 | 9.17 | 24.41 | Upgrade
|
| EV/Sales Ratio | 2.59 | 3.47 | 1.43 | 3.31 | 1.83 | 4.66 | Upgrade
|
| EV/EBITDA Ratio | 14.80 | 21.57 | 12.45 | 15.34 | 7.21 | 16.85 | Upgrade
|
| EV/EBIT Ratio | 22.47 | 32.32 | 42.01 | 20.08 | 9.06 | 18.84 | Upgrade
|
| EV/FCF Ratio | -10.70 | - | - | - | 4.53 | 35.92 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Debt / EBITDA Ratio | 0.28 | 0.28 | 0.13 | 0.13 | 0.19 | 0.15 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 0.12 | 0.31 | Upgrade
|
| Net Debt / Equity Ratio | -0.58 | -0.58 | -0.81 | -0.71 | -0.72 | -0.81 | Upgrade
|
| Net Debt / EBITDA Ratio | -8.87 | -8.87 | -23.61 | -9.84 | -7.53 | -5.06 | Upgrade
|
| Net Debt / FCF Ratio | 4.09 | 4.09 | 70.26 | 859.92 | -4.73 | -10.78 | Upgrade
|
| Asset Turnover | 0.35 | 0.35 | 0.26 | 0.30 | 0.32 | 0.68 | Upgrade
|
| Inventory Turnover | 6.97 | 6.97 | 6.14 | 6.65 | 4.47 | 5.48 | Upgrade
|
| Quick Ratio | 3.76 | 3.76 | 7.69 | 6.26 | 6.12 | 5.45 | Upgrade
|
| Current Ratio | 4.04 | 4.04 | 8.09 | 6.56 | 6.42 | 5.98 | Upgrade
|
| Return on Equity (ROE) | 4.17% | 4.17% | 1.04% | 6.30% | 8.12% | 20.61% | Upgrade
|
| Return on Assets (ROA) | 2.35% | 2.35% | 0.55% | 3.04% | 4.09% | 10.45% | Upgrade
|
| Return on Invested Capital (ROIC) | 9.29% | 13.16% | 3.23% | 16.70% | 28.44% | 87.07% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.30% | 4.30% | 1.00% | 5.40% | 7.40% | 13.80% | Upgrade
|
| Earnings Yield | 2.54% | 2.06% | 0.94% | 4.11% | 5.14% | 4.50% | Upgrade
|
| FCF Yield | -6.68% | -7.18% | -1.02% | -0.06% | 9.81% | 2.61% | Upgrade
|
| Dividend Yield | 1.13% | 0.75% | 0.55% | 1.06% | 1.53% | 1.31% | Upgrade
|
| Payout Ratio | 25.83% | 24.97% | 149.83% | 35.25% | 43.21% | 0.12% | Upgrade
|
| Buyback Yield / Dilution | 0.76% | 0.76% | -0.81% | -0.14% | -29.59% | -2.66% | Upgrade
|
| Total Shareholder Return | 1.83% | 1.51% | -0.27% | 0.92% | -28.06% | -1.34% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.